Blake Insomnia Therapeutics, Inc.
244, 5th Avenue
Suite A-154
New York
New York
10001
United States
Tel: 888-612-2905
Website: http://www.blakeinsomnia.com/
Email: help@blakeinsomnia.com
About Blake Insomnia Therapeutics, Inc.
Blake Insomnia Therapeutics, Inc. is a New York-based pharmaceutical company devoted to improving nighttime and daytime quality of life for people with insomnia. Our patent-pending compound, Zleepax™ (ZLX-1), has demonstrated efficacy without causing side effects identified as the No. 1 problem with current sleep medication. Blake Insomnia completed its reverse merger into NASDAQ OTC in second half of 2015.YEAR FOUNDED:
2012
LEADERSHIP:
Founder and CEO: Birger Jan Olsen
8 articles about Blake Insomnia Therapeutics, Inc.
-
Blake Insomnia Therapeutics Announces Submitting Clinical Trial Application For Phase II Clinical Testing
8/25/2017
-
Blake Insomnia Therapeutics Announces Appointment Of Morten Albrechtsen To Its Board Of Directors
6/16/2017
-
Blake Insomnia Therapeutics Announces Appointment Of Kyle Sarwal And Ajit Johal To Its Board Of Directors
5/25/2017
-
Blake Insomnia Therapeutics Announces Appointment Of Dr. Eric Leire To Its Board Of Directors
5/10/2017
-
Blake Insomnia Therapeutics Closes Joint Venture With Sajo Consulting LLC
2/27/2017
-
Blake Insomnia Therapeutics Enters A Joint Development With Sajo Consulting LLC
2/9/2017
-
Blake Insomnia Therapeutics Release: Company Seeks Financing For Clinical Trials
1/17/2017
-
Blake Insomnia Therapeutics Wants To Awaken A Billion Dollar Industry
12/22/2016